Insider · CIK 0001243025

James Steven P

Reports to the SEC for 4 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001243025

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−55.4K sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.8K sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,700 sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,700 sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−99.6K sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−86.8K sh	—	—	0
2025-05-15	Allakos Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−41K sh	—	—	0
2024-05-24	Allakos Inc.Stock Option (Right to buy)A Award	Director	AAward	+41K sh	—	—	41,000
2023-05-25	Allakos Inc.Stock Option (Right to buy)A Award	Director	AAward	+86.8K sh	—	—	86,762
2022-05-25	Allakos Inc.Stock Option (Right to buy)A Award	Director	AAward	+99.6K sh	—	—	99,590
2021-09-28	Allakos Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$0.53	+$2,100	4,000
2021-09-28	Allakos Inc.S Sale	Director	SSale	−4,000 sh	$108.12	−$432K	0
2021-09-28	Allakos Inc.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	55,380
2021-05-25	Allakos Inc.Stock Option (Right to buy)A Award	Director	AAward	+7,700 sh	—	—	7,700
2021-03-16	Allakos Inc.S Sale	Director	SSale	−3,500 sh	$121.65	−$426K	0
2021-03-16	Allakos Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,500 sh	$0.53	+$1,837.5	3,500
2021-03-16	Allakos Inc.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,500 sh	—	—	59,380
2020-05-26	Allakos Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,700 sh	—	—	7,700
2019-06-06	Allakos Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2018-03-09	Cascadian Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−13.7K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$1.52	−$19K	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2017-09-24	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,375 sh	—	—	14,271
2017-09-24	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−594 sh	$3.94	−$2,340.36	13,677
2017-09-24	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	−2,375 sh	—	—	0
2017-06-24	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,058 sh	—	—	14,161
2017-06-24	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−2,265 sh	$3.78	−$8,561.7	11,896
2017-06-24	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	−9,058 sh	—	—	0
2017-06-20	Ocera Therapeutics, Inc.A Award	Director	AAward	+12.5K sh	—	—	12,500
2017-06-12	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,148 sh	—	—	5,640
2017-06-12	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−537 sh	$3.34	−$1,793.58	5,103
2017-06-12	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	−2,148 sh	—	—	0
2017-06-09	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+13.9K sh	—	—	13,927
2017-03-12	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,656 sh	—	—	4,656
2017-03-12	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−1,164 sh	$4.35	−$5,063.4	3,492
2017-03-12	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	−4,656 sh	—	—	0
2016-06-24	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+54.3K sh	—	—	54,347
2016-06-14	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2015-09-24	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+14.2K sh	—	—	14,245
2015-06-18	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-06-12	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+12.9K sh	—	—	12,886
2015-03-12	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+27.9K sh	—	—	27,932
2014-09-17	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
May 154
James Steven P0001104659-25-049394
SEC(opens sec.gov)
May 294
James Steven P0000950170-24-065907
SEC(opens sec.gov)
May 304
James Steven P0001209191-23-032967
SEC(opens sec.gov)
May 274
James Steven P0001209191-22-032516
SEC(opens sec.gov)
Oct 144
James Steven P0001209191-21-060466
SEC(opens sec.gov)
Sep 294
James Steven P0001209191-21-058116
SEC(opens sec.gov)
Mar 174
James Steven P0001209191-21-021581
SEC(opens sec.gov)
May 284
James Steven P0000899243-20-014412
SEC(opens sec.gov)
Jun 114
James Steven P0000899243-19-016381
SEC(opens sec.gov)

Companies

Address

C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610

PALO ALTO, CA, 94301